Snake venoms are generally not dangerous when ingested, and are therefore not technically poisons.
Snake toxins have a great variety in their function. The two major families are neurotoxins (those that attack the nervous system) and cytotoxins (those that attack cells). They can be further subdivided as follows:
# Neurotoxins ## Fasciculins ## Dendrotoxins ## α-neurotoxins # Cytotoxins ## Phospholipases ## Cardiotoxins ## Haemotoxins
The beginning of a new impulse:
A) An exchange of ions (charged atoms) across the nerve cell membrane sends a depolarising current towards the end of the nerve cell (cell terminus).
B) When the depolarising current arrives at the nerve cell terminus, the neurotransmitter acetylcholine (ACh), which is held in vesicles, is released into the space between the two nerves (synapse). It moves across the synapse to the postsynaptic receptors.
C) If ACh remains at the receptor, the nerve stays stimulated, causing incontrollable muscle contractions. This condition is called tetany. So an enzyme called acetylcholinesterase destroys the ACh so tetany does not occur.
1) Fasciculins:
These toxins attack cholinergic neurons (those that use ACh as a transmitter) by destroying acetylcholinesterase (AChE). ACh therefore cannot be broken down and stays in the receptor. This causes tetany, which can lead to death.
Snake example: Black Mamba
2) Dendrotoxins:
Dendrotoxins inhibit neurotransmissions by blocking the exchange of + and – ions across the neuronal membrane ==> no nerve impulse. So it paralyses the nerves.
Snake example: Mambas
3) α-neurotoxins:
α-neurotoxins also attack cholinergic neurons. They mimic the shape of the acetylcholine molecule and therefore fit into the receptors → they block the ACh flow → feeling of numbness and paralysis.
Snake examples:
- Kraits use erabutoxin (the Many-banded krait uses Bungarotoxin)
- Cobras use cobratoxin,
1) Phospholipases:
Phospholipase is an enzyme that transforms the phospholipid molecule into a lysophospholipid (soap) ==> the new molecule attracts and binds fat and rips a hole in the cell membrane. Consequently water flows into the cell and destroys the molecules in it. That is called necrosis.
Snake example: The Japanese Habu snakes (low toxicity)
2) Cardiotoxins:
Actually cardiotoxins are muscle venoms. They bind to particular sites on the surface of muscle cells causing depolarisation ==> the toxin prevents muscle contraction. For example the heart muscle: the heart will beat irregularly and stop beating, which will cause death.
Snake example: King Cobra and some other cobras
3) Haemotoxins:
The toxin destroys red blood cells (erythrocytes). This symptom is called haemolysis. As it is a very slowly progressing venom it would probably not kill a human - another toxin in the snake’s venom would most certainly have caused death by then.
Snake example: most Vipers and the members of Naja genus
Snake cytotoxin
Two genera, Doliophis among the elapids and Causus among the viperids, are highly remarkable for having the venom gland and its duct of a great length, extending along each side of the body and terminating in front of the heart. Instead of the muscles of the temporal region serving to press out the venom into the duct, this action is performed by those of the side of the body.
When biting, a viperid snake merely strikes, discharging the venom the moment the fangs penetrate the skin, and then immediately lets it go. A proteroglyph or opisthoglyph, on the contrary, closes its jaws like a dog on the part bitten, often holding on firmly for a considerable time. The venom, which is mostly a clear, limpid fluid of a pale straw or amber colour, or rarely greenish, sometimes with a certain amount of suspended matter, is exhausted after several bites, and the glands have to recuperate.
Spitting is a defensive reaction only. The snake tends to aim for the eyes of a perceived threat; a direct hit can cause temporary shock and blindness through severe inflammation of the cornea and conjunctiva. While there are no serious results if the venom is washed away at once with plenty of water, the blindness caused by a successful spit can become permanent if left untreated. Contact with the skin is not in itself dangerous, but open wounds may become envenomated.
It is noteworthy that the size of the venom fangs is in no relation to the virulence of the venom. The comparatively innocent Indo-Malay Lachesis alluded to above have enormous fangs, whilst the smallest fangs are found in the Hydrophids which possess very potent venom.
The bite of all the proteroglyphous elapids, even of the smallest and gentlest, such as the Elaps or coral snakes, is, so far as known, deadly to humans.
The bite is immediately followed by local pain of a burning character; the limb soon swells and becomes discoloured, and within one to three hours great prostration, accompanied by vomiting, and often diarrhoea, sets in. Cold, clammy perspiration is usual. The pulse becomes extremely feeble, and slight dyspnoea and restlessness may be seen. In severe cases, which occur mostly in children, the pulse may become imperceptible and the extremities cold; the patient may pass into coma. In from twelve to twenty-four hours these severe constitutional symptoms usually pass off; but in the meantime the swelling and discoloration have spread enormously. The limb becomes phlegmonous, and occasionally suppurates. Within a few days recovery usually occurs somewhat suddenly, but death may result from the severe depression or from the secondary effects of suppuration. That cases of death, in adults as well as in children, are not infrequent in some parts of the Continent is mentioned in the last chapter of this Introduction.
The Viperidae differ much among themselves in the toxicity of their venom. Some, such as the Indian Daboia russelli and Echis carinatus; the American vipers Crotalus, Lachesis muta and Bothrops lanceolatus; and the African Causus, Bitis, and Cerastes, cause fatal results unless a remedy is speedily applied. On the other hand, the Indian and Malay Lachesis seldom cause the death of humans, their bite in some instances being no worse than the sting of a hornet. The bite of the larger European vipers may be very dangerous, and followed by fatal results, especially in children, at least in the hotter parts of the Continent; whilst the small Vipera ursinii, which hardly ever bites unless roughly handled, does not seem to be possessed of a very virulent venom, and, although very common in some parts of Austria-Hungary, is not known to have ever caused a serious accident.
Boomslang and vine snake venom are toxic to blood cells and thin the blood (hemotoxic, hemorrhagic). Early symptoms include headaches, nausea, diarrhea, lethargy, mental disorientation, bruising and bleeding at the site and all body openings. Exsanguination is the main cause of death from such a bite.
The Groen Boomslang's venom is the most potent of all rear-fanged snakes in the world. Although it has venom more potent that many vipers and some elapids, it causes fewer fatalities. This is because the Groen Boomslang only secretes a small amount of venom when it bites and because it is much less aggressive in comparison to other venomous snakes such as the Black Mamba .
Symptoms of a bite from these snakes are nausea and internal bleeding, and one could die from a brain hemorrhage and respiratory collapse.
The studies to which we allude have not only conduced to a method of treatment against snake-bites, but have thrown a new light on the great problem of immunity.
They have shown that the antitoxic sera do not act as chemical antidotes in destroying the venom, but as physiological antidotes; that, in addition to the venom glands, snakes possess other glands supplying their blood with substances antagonistic to the venom, such as also exist in various animals refractory to snake venom, the hedgehog and the mongoose for instance.
Thus, a European in Australia who had become immune to the venom of the deadly Australian Tiger Snake, Notechis scutatus, manipulating these snakes with impunity, and was under the impression that his immunity extended also to other species, when bitten by a Denisonia superba, an allied elapine, died the following day.
In India, the serum prepared with the venom of Naja tripudians has been found to be without effect on the venom of the two species of kraits of the genus Bungarus, and the Old World vipers Daboia russelli and Echis carinatus, and the pit viper Trimeresurus popeiorum. Daboia russelli serum is without effect on colubrine venoms, or those of Echis and Trimeresurus.
In Brazil, serum prepared with the venom of the New World pit viper Lachesis lanceolatus is without action on Crotalus venom.
Antivenom snakebite treatment must be matched as the type of envenomation that has occurred.
In the Americas, polyvalent antivenoms are available that are effective against the bites of most pit vipers.
These are not effective against coral snake envenomation, which requires a specific antivenom to their neurotoxic venom.
The situation is even more complex in countries like India, with its rich mix of vipers (family Viperidae) and highly neurotoxic cobras and kraits of the family Elapidae.
This article is based on the 1913 book The Snakes of Europe, by G. A. Boulenger, which is now in the public domain in the United States (and possibly elsewhere) because of its age. Because of its age, the text in this article should not necessarily be viewed as reflecting the current knowledge of snake venom.
This text is licensed under the Creative Commons CC-BY-SA License. This text was originally published on Wikipedia and was developed by the Wikipedia community.
The World News (WN) Network, has created this privacy statement in order to demonstrate our firm commitment to user privacy. The following discloses our information gathering and dissemination practices for wn.com, as well as e-mail newsletters.
We do not collect personally identifiable information about you, except when you provide it to us. For example, if you submit an inquiry to us or sign up for our newsletter, you may be asked to provide certain information such as your contact details (name, e-mail address, mailing address, etc.).
When you submit your personally identifiable information through wn.com, you are giving your consent to the collection, use and disclosure of your personal information as set forth in this Privacy Policy. If you would prefer that we not collect any personally identifiable information from you, please do not provide us with any such information. We will not sell or rent your personally identifiable information to third parties without your consent, except as otherwise disclosed in this Privacy Policy.
Except as otherwise disclosed in this Privacy Policy, we will use the information you provide us only for the purpose of responding to your inquiry or in connection with the service for which you provided such information. We may forward your contact information and inquiry to our affiliates and other divisions of our company that we feel can best address your inquiry or provide you with the requested service. We may also use the information you provide in aggregate form for internal business purposes, such as generating statistics and developing marketing plans. We may share or transfer such non-personally identifiable information with or to our affiliates, licensees, agents and partners.
We may retain other companies and individuals to perform functions on our behalf. Such third parties may be provided with access to personally identifiable information needed to perform their functions, but may not use such information for any other purpose.
In addition, we may disclose any information, including personally identifiable information, we deem necessary, in our sole discretion, to comply with any applicable law, regulation, legal proceeding or governmental request.
We do not want you to receive unwanted e-mail from us. We try to make it easy to opt-out of any service you have asked to receive. If you sign-up to our e-mail newsletters we do not sell, exchange or give your e-mail address to a third party.
E-mail addresses are collected via the wn.com web site. Users have to physically opt-in to receive the wn.com newsletter and a verification e-mail is sent. wn.com is clearly and conspicuously named at the point of
collection.If you no longer wish to receive our newsletter and promotional communications, you may opt-out of receiving them by following the instructions included in each newsletter or communication or by e-mailing us at michaelw(at)wn.com
The security of your personal information is important to us. We follow generally accepted industry standards to protect the personal information submitted to us, both during registration and once we receive it. No method of transmission over the Internet, or method of electronic storage, is 100 percent secure, however. Therefore, though we strive to use commercially acceptable means to protect your personal information, we cannot guarantee its absolute security.
If we decide to change our e-mail practices, we will post those changes to this privacy statement, the homepage, and other places we think appropriate so that you are aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it.
If we make material changes to our e-mail practices, we will notify you here, by e-mail, and by means of a notice on our home page.
The advertising banners and other forms of advertising appearing on this Web site are sometimes delivered to you, on our behalf, by a third party. In the course of serving advertisements to this site, the third party may place or recognize a unique cookie on your browser. For more information on cookies, you can visit www.cookiecentral.com.
As we continue to develop our business, we might sell certain aspects of our entities or assets. In such transactions, user information, including personally identifiable information, generally is one of the transferred business assets, and by submitting your personal information on Wn.com you agree that your data may be transferred to such parties in these circumstances.